Literature DB >> 18519959

Animal models for the molecular and mechanistic study of lymphatic biology and disease.

William S Shin1, Stanley G Rockson.   

Abstract

The development of animal model systems for the study of the lymphatic system has resulted in an explosion of information regarding the mechanisms governing lymphatic development and the diseases associated with lymphatic dysfunction. Animal studies have led to a new molecular model of embryonic lymphatic vascular development, and have provided insight into the pathophysiology of both inherited and acquired lymphatic insufficiency. It has become apparent, however, that the importance of the lymphatic system to human disease extends, beyond its role in lymphedema, to many other diverse pathologic processes, including, very notably, inflammation and tumor lymphangiogenesis. Here, we have undertaken a systematic review of the models as they relate to molecular and functional characterization of the development, maturation, genetics, heritable and acquired diseases, and neoplastic implications of the lymphatic system. The translation of these advances into therapies for human diseases associated with lymphatic dysfunction will require the continued study of the lymphatic system through robust animal disease models that simulate their human counterparts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519959     DOI: 10.1196/annals.1413.005

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  21 in total

1.  Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis.

Authors:  Xiao-Mei Yang; Hai-Xiong Han; Fei Sui; Yu-Min Dai; Ming Chen; Jian-Guo Geng
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

2.  Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C).

Authors:  Xin Yin; Scott C Johns; Roger Lawrence; Ding Xu; Krisanavane Reddi; Joseph R Bishop; Judith A Varner; Mark M Fuster
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

Review 3.  Lymphangiogenesis: a new player in cancer progression.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Omar M Rashid; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

4.  Modified Mouse Models of Chronic Secondary Lymphedema: Tail and Hind Limb Models.

Authors:  Heungman Jun; Ji Yoon Lee; Ji Hun Kim; Minsu Noh; Tae-Won Kwon; Yong-Pil Cho; Young-Sup Yoon
Journal:  Ann Vasc Surg       Date:  2017-05-04       Impact factor: 1.466

Review 5.  Role of intestinal lymphatics in interstitial volume regulation and transmucosal water transport.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

6.  Lymphatic deletion of calcitonin receptor-like receptor exacerbates intestinal inflammation.

Authors:  Reema B Davis; Daniel O Kechele; Elizabeth S Blakeney; John B Pawlak; Kathleen M Caron
Journal:  JCI Insight       Date:  2017-03-23

7.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Authors:  Michael J Flister; Andrew Wilber; Kelly L Hall; Caname Iwata; Kohei Miyazono; Riccardo E Nisato; Michael S Pepper; David C Zawieja; Sophia Ran
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

Review 8.  Reclaiming a natural beauty: whole-organ engineering with natural extracellular materials.

Authors:  Samantha Traphagen; Pamela C Yelick
Journal:  Regen Med       Date:  2009-09       Impact factor: 3.806

9.  A Murine Tail Lymphedema Model.

Authors:  Aladdin H Hassanein; Mithun Sinha; Colby R Neumann; Ganesh Mohan; Imran Khan; Chandan K Sen
Journal:  J Vis Exp       Date:  2021-02-10       Impact factor: 1.355

10.  Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.

Authors:  Sophia Ran; Kyle E Montgomery
Journal:  Cancers (Basel)       Date:  2012-06-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.